Skip to main content
Cantourage Group SE logo

Cantourage Group SE — Investor Relations & Filings

Ticker · HIGH ISIN · DE000A3DSV01 LEI · 3912003NCTLO6YHA9V48 XMIL Manufacturing
Open in API
Filings indexed 109 across all filing types
Latest filing 2026-05-11 Earnings Release
Country DE Germany
Listing XMIL HIGH

About Cantourage Group SE

https://www.cantourage.com/

Cantourage Group SE is a company specializing in the production and distribution of medical cannabis. It operates a platform that enables global cultivators to access the European market by managing the import, processing, and distribution of cannabis products. The company processes raw materials from its international partners into EU-compliant finished medicinal products, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Its portfolio features a diverse range of cannabis strains. Additionally, Cantourage operates the 'Telecan' telemedicine platform to facilitate patient access to cannabis-based therapies. The company's strategy involves developing new cannabis medicines and working to lower the cost of treatment for patients.

Recent filings

Filing Released Lang Actions
Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026
Earnings Release Classification · 92% confidence The document is a corporate news announcement of the company’s first-quarter 2026 financial performance, featuring key metrics (revenue growth, EBITDA, margin, net cash position), business highlights, geographic breakdown, and outlook. It is not the full interim report with complete financial statements but rather an initial earnings announcement. This matches the “Earnings Release” category (ER). Q1 2026
2026-05-11 English
Cantourage Group SE: U.S. Cannabis Rescheduling Highlights Global Growth Potential Europe Comes into Focus
Regulatory Filings Classification · 85% confidence The document is a corporate news announcement discussing regulatory developments in U.S. cannabis scheduling and its implications for Cantourage’s global growth strategy. It does not present detailed financial results (ruling out ER, IR, 10-K), nor is it a management change, shareholding notice, or proxy statement. It is a general corporate press release/regulatory announcement serving as a fallback category. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-04-24 English
Cantourage Group SE publishes preliminary figures for 2025 Revenue rises to EUR 92.8 million
Earnings Release Classification · 100% confidence The document is a corporate news release announcing preliminary financial figures for the 2025 fiscal year. It highlights key metrics like revenue and EBITDA growth, discusses strategic market positioning, and explicitly states that the figures are preliminary and unaudited. As this is an initial announcement of financial results rather than the full audited annual report, it falls under the Earnings Release (ER) category. FY 2025
2026-03-17 English
Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures
Regulatory Filings Classification · 98% confidence The document is an 'Ad-hoc' announcement regarding inside information under Article 17 MAR. It provides a preliminary update on EBITDA expectations for the 2025 financial year, stating that the company expects to exceed current market consensus. Since this is an initial announcement of financial performance highlights rather than a full report, and it does not fit into specific categories like dividend announcements or share buybacks, it is classified as an Earnings Release (ER).
2025-12-19 English
Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer Supervisory Board prolongs CEO Philip Schetter's mandate by five years
Board/Management Information Classification · 100% confidence The document is a corporate news announcement regarding the appointment of a new CFO and the extension of the CEO's mandate at Cantourage Group SE. This falls under the category of changes in senior management, which is explicitly defined as 'Board/Management Information' (MANG).
2025-12-09 English
Cantourage strengthens market presence in Poland with flower variety Gelato 33
Regulatory Filings Classification · 100% confidence The document is a corporate news release issued by Cantourage Group SE regarding their business expansion in the Polish medical cannabis market. It does not contain financial statements, audit reports, or regulatory filings, but rather serves as a press release/corporate news update. According to the provided definitions and the 'Regulatory Filings' fallback rule for miscellaneous corporate news, this is classified as an RNS (Regulatory News Service/Regulatory Filing).
2025-11-04 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.